The purpose of this study is to learn if the use of inhaled cannabis (marijuana) and oral
cannabinoid (dronabinol, Marinol or THC, which is an active ingredient of marijuana) is safe
and effective in reducing the symptoms of spasticity and tremor in patients with
secondary-progressive or primary progressive multiple sclerosis.